Literature DB >> 34159172

Alcohol consumption leads to loss of healthy life, but the ADH1B*2 allele may still protect from NASH.

Guillermo Mazzolini1,2, Ali Canbay3.   

Abstract

Entities:  

Year:  2021        PMID： 34159172      PMCID： PMC8188130          DOI： 10.21037/hbsn-21-49

Source DB:  PubMed          Journal:  Hepatobiliary Surg Nutr        ISSN： 2304-3881            Impact factor:   7.293


× No keyword cloud information.
  15 in total

1.  Interaction between the functional polymorphisms of the alcohol-metabolism genes in protection against alcoholism.

Authors:  C C Chen; R B Lu; Y C Chen; M F Wang; Y C Chang; T K Li; S J Yin
Journal:  Am J Hum Genet       Date:  1999-09       Impact factor: 11.025

2.  Mendelian randomisation suggests no beneficial effect of moderate alcohol consumption on the severity of nonalcoholic fatty liver disease.

Authors:  S Sookoian; D Flichman; G O Castaño; C J Pirola
Journal:  Aliment Pharmacol Ther       Date:  2016-10-24       Impact factor: 8.171

3.  Alcohol dehydrogenase-1B genotype (rs1229984) is a strong determinant of the relationship between body weight and alcohol intake in Japanese alcoholic men.

Authors:  Akira Yokoyama; Tetsuji Yokoyama; Toshifumi Matsui; Takeshi Mizukami; Sachio Matsushita; Susumu Higuchi; Katsuya Maruyama
Journal:  Alcohol Clin Exp Res       Date:  2013-02-15       Impact factor: 3.455

4.  ADH1B∗2 Is Associated With Reduced Severity of Nonalcoholic Fatty Liver Disease in Adults, Independent of Alcohol Consumption.

Authors:  Eduardo Vilar-Gomez; Silvia Sookoian; Carlos Jose Pirola; Tiebing Liang; Samer Gawrieh; Oscar Cummings; Wanqing Liu; Naga P Chalasani
Journal:  Gastroenterology       Date:  2020-05-23       Impact factor: 22.682

Review 5.  Genetic polymorphisms of alcohol metabolizing enzymes.

Authors:  D P Agarwal
Journal:  Pathol Biol (Paris)       Date:  2001-11

6.  Determinants of progression to cirrhosis or fibrosis in pure alcoholic fatty liver.

Authors:  M R Teli; C P Day; A D Burt; M K Bennett; O F James
Journal:  Lancet       Date:  1995-10-14       Impact factor: 79.321

7.  Among Patients With Nonalcoholic Fatty Liver Disease, Modest Alcohol Use Is Associated With Less Improvement in Histologic Steatosis and Steatohepatitis.

Authors:  Veeral Ajmera; Patricia Belt; Laura A Wilson; Ryan M Gill; Rohit Loomba; David E Kleiner; Brent A Neuschwander-Tetri; Norah Terrault
Journal:  Clin Gastroenterol Hepatol       Date:  2018-03-14       Impact factor: 11.382

8.  Resveratrol amplifies profibrogenic effects of free fatty acids on human hepatic stellate cells.

Authors:  Lars P Bechmann; Denis Zahn; Robert K Gieseler; Christian D Fingas; Guido Marquitan; Christoph Jochum; Guido Gerken; Scott L Friedman; Ali Canbay
Journal:  Hepatol Res       Date:  2009-01-14       Impact factor: 4.288

Review 9.  Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes.

Authors:  Zobair M Younossi; Aaron B Koenig; Dinan Abdelatif; Yousef Fazel; Linda Henry; Mark Wymer
Journal:  Hepatology       Date:  2016-02-22       Impact factor: 17.425

10.  Low Levels of Alcohol Consumption, Obesity, and Development of Fatty Liver With and Without Evidence of Advanced Fibrosis.

Authors:  Yoosoo Chang; Seungho Ryu; Yejin Kim; Yong Kyun Cho; Eunju Sung; Han-Na Kim; Jiin Ahn; Hyun-Suk Jung; Kyung Eun Yun; Seolhye Kim; Ki-Chul Sung; Chong Il Sohn; Hocheol Shin; Sarah H Wild; Christopher D Byrne
Journal:  Hepatology       Date:  2019-10-10       Impact factor: 17.425
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.